4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000106
EVP, Chief Technical Ops. Off. sold 668 shares at $486.35 ($324,882)
- EVP, Chief Technical Ops. Off. gave up 1,627 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Atkinson Edward Morrow III · EVP, Chief Technical Ops. Off.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-24 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −1,627 | $485.11 | $789,274 | 19,100 | D |
| 2026-02-25 | Sale : show line 2 in the form 10b5-1 | −668 | $486.35 | $324,882 | 18,432 | D |
| Open-market sales · 668 sh · avg $486.35 · $324,882 | ||||||
Loading xslF345X05/wk-form4_1772146808.xml…